Abstract

Globally, there is a huge demand for novel agents capable of providing protection against both pathogen microorganisms and tumor cells. In this study, the antimicrobial, biofilm inhibitory, and anticancer effects of glycine and glycyl-glycine were investigated. The antimicrobial effects were determined using the broth dilution method, while the biofilm inhibitory effects were assessed through the crystal violet binding assay. Cytotoxic effects on HeLa cell viability were measured using the MTT assay. Our results indicate that, although 100 mg/mL of glycine only inhibited S. epidermidis W17 among the three tested isolates, 400 mg/mL of glycyl-glycine inhibited both S. epidermidis W17 and P. mirabilis U15 strains. Additionally, sub-MICs (concentrations below the Minimum Inhibition Concentration) of glycine inhibited biofilm formation by more than 70% in all tested clinical isolates and exhibited significantly more biofilm inhibition against P. mirabilis U15 and S. epidermidis W17 strains (p

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.